Baxter works to improve hemophilia medicine, drug delivery methods

03/15/2007 | Chicago Sun-Times (free registration)

Finding less painful ways to deliver intravenous drugs, improving hemophilia medicine, and developing therapies using adult stem cells to treat heart conditions and bone and tissue repair products are among the research and development projects announced this week by Chicago-based Baxter International.

View Full Article in:

Chicago Sun-Times (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ